Erratum: Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.

IF 44.7 1区医学 Q1 ONCOLOGY

Journal of Clinical Oncology Pub Date : 2026-10-20 Epub Date: 2026-09-17 DOI:10.1200/JCO-26-02285

Alwin Krämer, Tilmann Bochtler, Chantal Pauli, Kai-Keen Shiu, Natalie Cook, Juliana Janoski de Menezes, Roberto A Pazo-Cid, Ferran Losa, Debbie G J Robbrecht, Jiří Tomášek, Cagatay Arslan, Mustafa Özgüroğlu, Panoraia Arni, Frederic Bigot, Sun Young Kim, Yoichi Naito, Antoine Italiano, Nasséra Chalabi, Gonzalo Durán-Pacheco, Ning Ma, Jeremy Scarato, Jeffrey S Ross, Holger Moch, Linda Mileshkin

引用次数: 0

查看原文本刊更多论文

勘误：分子引导治疗与继续化疗治疗原发不明的不利癌症：来自随机II期CUPISCO研究的最新疗效和安全性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Oncology 医学-肿瘤学

CiteScore

41.20

自引率

2.20%

发文量

8215

审稿时长

2 months

期刊介绍： The Journal of Clinical Oncology serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research. Original Reports remain the focus of JCO, but this scientific communication is enhanced by appropriately selected Editorials, Commentaries, Reviews, and other work that relate to the care of patients with cancer.